No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Combined Modality Therapy / adverse effects
-
Combined Modality Therapy / trends
-
Cost of Illness
-
Drug Approval
-
Drugs, Investigational / adverse effects
-
Drugs, Investigational / therapeutic use*
-
Evidence-Based Medicine*
-
Female
-
Gonadotropin-Releasing Hormone / antagonists & inhibitors
-
Gonadotropin-Releasing Hormone / metabolism
-
Hormone Antagonists / adverse effects
-
Hormone Antagonists / therapeutic use
-
Humans
-
Leiomyoma / drug therapy*
-
Leiomyoma / metabolism
-
Leiomyoma / physiopathology
-
Leiomyoma / therapy
-
Leiomyomatosis / drug therapy*
-
Leiomyomatosis / metabolism
-
Leiomyomatosis / physiopathology
-
Leiomyomatosis / therapy
-
Menorrhagia / etiology
-
Menorrhagia / prevention & control
-
Quality of Life
-
Receptors, Progesterone / antagonists & inhibitors
-
Receptors, Progesterone / metabolism
-
United States
-
United States Food and Drug Administration
-
Uterine Neoplasms / drug therapy*
-
Uterine Neoplasms / metabolism
-
Uterine Neoplasms / physiopathology
-
Uterine Neoplasms / therapy
Substances
-
Drugs, Investigational
-
Hormone Antagonists
-
Receptors, Progesterone
-
Gonadotropin-Releasing Hormone